Why Menopause Could Be Your Company's $1.8 Billion Blind Spot

Let's get right to it: menopause is derailing careers and costing companies billions. Yet, most workplaces aren't prepared to address it. Here's the kicker: only 11% of companies offer menopause-related benefits. This means the majority are ignoring a significant health issue impacting their workforce right at the peak of their careers.

The Story

Kacy Fleming found herself in the middle of a boardroom presentation when an unexpected hot flash took her by surprise. The burning sensation was more than physical, it was symbolic of a deeper issue. Fleming was battling perimenopause, a stage she hadn't even heard of despite 22 years in healthcare. Not only did it affect her career as the head of global well-being at Takeda, but it also threatened her personal life.

Her story isn't unique. Women like Emily Thompson and Paige Dunn faced similar battles. Thompson left a high-growth startup due to uncontrolled symptoms. Dunn found solace in hormone replacement therapy (HRT), which transformed her work life within ten days. But why are these stories more common than they should be?

The average age of menopause in the U.S. is 52, not far from the average age of a newly hired CEO, which is 54. Yet only 11% of Fortune 500 companies have female CEOs. Coincidence? Hardly. Menopause symptoms, including hot flashes and mood swings, are cited by 65% of women as having a negative impact on their work performance, leading some to consider early retirement or job changes.

Analysis

So, what's the real impact? For starters, the economic hit is substantial. Absenteeism and turnover related to menopause symptoms cost U.S. employers an estimated $1.8 billion annually. That figure doesn't even touch on the cost of replacing trained leaders, estimated to be 150% to 200% of an employee’s salary. This is no small number.

Why are companies dragging their feet? Perhaps it's the double stigma, being both 'older' and female in the workplace. A 2024 survey found that almost three in four women hide their symptoms at work. The stigma is real, and it's costly.

But here's where it gets interesting. Companies like Midi and Maven are filling the gap with telehealth services, offering HRT and training for menopause care. This is important as fewer than 20% of primary care physicians receive menopause training. Companies that embrace these solutions couldn't only save money but also retain experienced leaders.

The Takeaway

The path forward is clear: it's time for companies to acknowledge menopause as a important workplace issue. This means offering health insurance that covers menopause treatments and creating flexible work arrangements. Paige Dunn's experience showed that even a low-dose HRT prescription dramatically improved her quality of life. If implemented company-wide, such policies could enhance productivity and employee satisfaction.

But why stop there? Empower women to speak openly about menopause without fear of judgment. Normalize conversations around menopause in the workplace. After all, half of Gen X will be in their menopause years by 2030. It's not just a women's issue, it affects everyone, including colleagues and families.

Ignoring menopause isn't just bad for employees. it's bad for business. Are we willing to let outdated stigmas dictate workplace culture and profitability? That's the real question.